Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection

Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide; however, accurate prognostic tools are still lacking. We aimed to identify immunohistochemistry (IHC)-based signature as a prognostic classifier to predict recurrence and survival in patients with HCC at Barcelona Clinic Liver...

詳細記述

保存先:
書誌詳細
出版年:Front Oncol
主要な著者: Bai, Yannan, Lian, Yuane, Chen, Xiaoping, Wu, Jiayi, Lai, Jianlin, Qiu, Funan, Zhou, Songqiang, Zhu, Zijing, Tian, Yifeng, Wang, Yaodong, Yang, Yinghong, Yan, Maolin
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2021
主題:
Oncology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7874098/
https://ncbi.nlm.nih.gov/pubmed/33585243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.616263
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料